Angiolite Sirolimus-Eluting Coronary Stent

An ultra-thin cobalt-chromium stent with a durable fluorinated coating, delivering sirolimus for enhanced flexibility and high over-expansion capacity in coronary interventions.

Why It Matters

The Angiolite Sirolimus-Eluting Coronary Stent combines an open-cell cobalt-chromium design with a controlled sirolimus release, offering superior deliverability and flexibility for treating coronary artery disease, minimizing restenosis and improving long-term patient outcomes.

Highlights and Features

Thin struts (75–85 µm) for enhanced flexibility and reduced vessel trauma.
Multi-layer fluorinated acrylic coating with 1.4 µg/mm² sirolimus for controlled drug elution.
Low-profile design (0.016″ tip) with hydrophilic balloon coating for excellent deliverability.
Radiopaque Pt-Ir markers for precise positioning under fluoroscopy.
Open-cell design with alternating links for consistent arterial coverage.
High over-expansion capacity (up to 6 mm) for large vessels.

Technical Specifications

Material	Cobalt-Chromium L605
Strut Thickness	75–85 µm
Drug Dose	1.4 µg/mm² Sirolimus
Coating	Durable fluorinated polymer
Delivery System	Rapid-exchange catheter, 0.016″ tip, 5F compatible
Balloon Specifications	Nylon and Pebax multi-layer, NP 9–12 atm, RBP 16 atm, ABP 22 atm
Stent Diameters	2.0–4.5 mm
Stent Lengths	9–49 mm (CE-marked)
Over-expansion Capacity	Up to 6 mm (large vessels); 4–5.25 mm (smaller vessels)

Clinical Applications

The Angiolite stent is designed for percutaneous coronary intervention (PCI) to treat coronary artery disease, including de novo lesions and restenotic lesions. Supported by clinical evidence (ANCHOR study: 1% TLR, 0% stent thrombosis; ANGIOLITE trial: 0.04 mm late loss), it ensures effective vessel patency and minimal neointimal growth, making it ideal for complex coronary anatomies.